Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | April 29, 2021 |
| Target | Park Therapeutics |
| Sector | Life Science |
| Buyer(s) | Tris Pharma |
| Deal Type | Add-on Acquisition |
FILTER BY
| Category | Company |
|---|---|
| Founded | 2000 |
| Sector | Life Science |
Tris Pharma, Inc. is a fully integrated pharmaceutical company focused on the development of innovative medicines that address unmet patient needs. Tris Pharma, Inc. was founded in 2000 and is based in Monmouth Junction, New Jersey.
| Deal Context for Buyer | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science | 2 of 2 |
| Type: Add-on Acquisition | 1 of 1 |
| State: New Jersey | 1 of 1 |
| Country: United States | 2 of 2 |
| Year: 2021 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-09-25 |
NextWave Pharmaceuticals
Cupertino, California, United States NextWave Pharmaceuticals is a specialty pharmaceutical company developing extended release OTC and prescription products for children and adults. NextWave Pharmaceuticals was founded in 2005 and is based in Cupertino, California. |
Buy | - |
